Insulin-like growth factor I, but not neurotrophin-3, sustains Akt activation and provides long-term protection of immature oligodendrocytes from glutamate-mediated apoptosis

Molecular and Cellular Neuroscience

Volumn 20, Issue 3, 2002, Pages 476-488

  Ness, Jennifer K ^a   Wood, Teresa L ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE 3; CILIARY NEUROTROPHIC FACTOR; DNA FRAGMENT; GLUTAMIC ACID; NEUROTROPHIN 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR; TYROSINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; ENZYME ACTIVATION; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR UPREGULATION;

ANIMALIA;

EID: 0036355914     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2002.1149     Document Type: Article

References (58)

1. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion
2. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury
3. Multiple extracellular signals are required for long-term oligodendrocyte survival
4. Igf1 gene disruption results in reduced brain size, CNS hypomelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons
5. IGF-I promotes Schwann cell motility and survival via activation of Akt
6. Insulin-like growth factor-I receptor internalization regulates signaling via the Shc/mitogen-activated protein kinase pathway, but not the insulin receptor substrate-1 pathway
7. Preclinical testing of neuroprotective neurotrophic factors in a model of chronic motor neuron degeneration
8. Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury
9. Regulation of neuronal survival by the serine-threonine protein kinase akt
10. Distinct roles for PI3K in proliferation and survival of oligodendrocyte progenitor cells
11. Rapid ischemic cell death in immature oligodendrocytes: A fatal glutamate release feedback loop
12. Akt-mediated survival of oligodendrocytes induced by neuregulins
13. NBQX attenuates excitotoxic injury in developing white matter
14. BDNF down-regulates neurotrophin responsiveness, TrkB protein and TrkB mRNA levels in cultured rat hippocampal neurons
15. Intergrin signaling via the PI3-kinase-Akt pathway increases neuronal resistance to glutamate-induced apoptosis
16. Endogenous progenitors remyelinate demyelinated axons in the adult CNS
17. Insulin-like growth factor-1 reduces postischemic white matter injury in fetal sheep
18. Neurotrophin-3 mediates the autocrine survival of the catecholaminergic CAD CNS neuronal cell line
19. Preferential injury of oligodendroblasts by a short hypoxic-ischemic insult
20. IGF-I synergizes with FGF-2 to stimulate oligodendrocyte progenitor entry into the cell cycle
21. Neurotrophin-3 (NT-3) diminishes susceptibility of the oligodendroglial lineage to AMPA glutamate receptor-mediated excitotoxicity
22. Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 in vivo
23. Ligand-induced down-regulation of Trk messenger RNA, protein and tyrosine phosphorylation in rat cortical neurons
24. Insulin-like growth factor I gene expression is induced in astrocytes during experimental demyelination
25. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt
26. Coordinate IGF-I and IGFBP5 gene expression in perinatal rat brain after hypoxia-ischemia
27. Novel injury mechanism in anoxia and trauma of spinal cord white matter: Glutamate release via reverse Na+-dependent glutamate transport
28. Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolated spinal cord white matter
29. Insulin-like gorwth factor I treatment reduces clinical deficites and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis
30. Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage
31. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death
32. Mature oligodendrocyte apoptosis precedes IGF-I production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination
33. Interleukin-1B promotes repair of the CNS
34. Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination
35. The link between excitotoxic oligodendroglial death and demyelinating diseases
36. Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes
37. Oligodendrocytes from forebrain are highly vulnerable to AKPA/kainate receptor-mediated excitotoxicity
38. Multiple classes of the oligodendrocyte lineage are highly vulnerable to excitotoxicity
39. Perinatal hypoxia-ischemia induces apoptotic and excitotoxic death of periventricular white matter oligodendrocyte progenitors
40. Glutamate release and neuronal damage in ischemia
41. Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptors
42. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis
43. Glutamate excitotoxicity in a model of multiple sclerosis
44. The nature and regulation of the receptors for insulin-like growth factors
45. Insulin-like growth factor-I prevents apoptosis in neurons after nerve growth factor withdrawal
46. AMPA and kainate receptors each mediate excitotoxicity in oligodendroglial cultures
47. Autoimmune encephalomyelitis ameliorated by AMPA antagonists
48. BDNF and NT-3 but not CNTF conteract the Ca2+ ionophore-induced apoptosis of cultured cortical neurons: Involvement of dual pathways
49. Oligodendrocytes and their precursors require phosphatidylinositol 3-kinase signaling for survival
50. Brain injury in the premature infant - From pathogenesis to prevention
51. Perintal brain injury: From pathogenesis to neuroprotection
52. Multiple sclerosis: Altered glutamate homeostasis in lesions correlates with oligodendrocyte and axonal damage
53. Insulin-like growth factor-I given subcutaneously reduces clinical deficits, decreases lesion severity and upregulates synthesis of myelin proteins in experimental autoimmune encephalomyelitis
54. Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury
55. α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage
56. Non-N-methyl-D-aspartate glutamate receptors mediate oxygen-glucose deprivation-induced oligodendroglial injury
57. Comparison of the intracellular itineraries of insulin-like growth factor-I and insulin and their receptors in Rat-1 fibroblasts
58. Cell surface Trk receptors mediate NGF-induced survival while internalized receptors regulate NGF-induced differentiation